Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: methylprednisolone
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: in vitro-treated bone marrow transplantation
RADIATION: radiation therapy

Sponsor

Chimeric Therapies